These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 29145169

  • 1. A zinc Schiff base complex inhibits cancer progression both in vivo and in vitro by inducing apoptosis.
    Banerjee A, Banerjee K, Sinha A, Das S, Majumder S, Majumdar S, Choudhuri SK.
    Environ Toxicol Pharmacol; 2017 Dec; 56():383-392. PubMed ID: 29145169
    [Abstract] [Full Text] [Related]

  • 2. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K, Biswas MK, Choudhuri SK.
    J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
    [Abstract] [Full Text] [Related]

  • 3. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
    Ghosh RD, Das S, Ganguly A, Banerjee K, Chakraborty P, Sarkar A, Chatterjee M, Nanda A, Pradhan K, Choudhuri SK.
    Dalton Trans; 2011 Nov 07; 40(41):10873-84. PubMed ID: 21717020
    [Abstract] [Full Text] [Related]

  • 4. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
    Banerjee K, Basu S, Das S, Sinha A, Biswas MK, Choudhuri SK.
    Free Radic Res; 2016 Nov 07; 50(4):426-46. PubMed ID: 26733073
    [Abstract] [Full Text] [Related]

  • 5. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
    Ganguly A, Banerjee K, Chakraborty P, Das S, Sarkar A, Hazra A, Banerjee M, Maity A, Chatterjee M, Mondal NB, Choudhuri SK.
    Biomed Pharmacother; 2011 Sep 07; 65(6):387-94. PubMed ID: 21715129
    [Abstract] [Full Text] [Related]

  • 6. A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression.
    Banerjee K, Das S, Sarkar A, Chatterjee M, Biswas J, Choudhuri SK.
    Biomed Pharmacother; 2016 Dec 07; 84():71-92. PubMed ID: 27639544
    [Abstract] [Full Text] [Related]

  • 7. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
    Ganguly A, Basu S, Banerjee K, Chakraborty P, Sarkar A, Chatterjee M, Chaudhuri SK.
    Mol Biosyst; 2011 May 07; 7(5):1701-12. PubMed ID: 21409205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
    Mahendiran D, Kumar RS, Viswanathan V, Velmurugan D, Rahiman AK.
    J Biol Inorg Chem; 2017 Oct 07; 22(7):1109-1122. PubMed ID: 28884428
    [Abstract] [Full Text] [Related]

  • 10. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer.
    Basu S, Ganguly A, Chakraborty P, Sen R, Banerjee K, Chatterjee M, Efferth T, Choudhuri SK.
    Biochimie; 2012 Jan 07; 94(1):166-83. PubMed ID: 22037022
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A, Mookerjee Basu J, Dutta P, Majumder S, Bhattacharyya S, Biswas J, Pal S, Mukherjee P, Raha S, Baral RN, Das T, Efferth T, Sa G, Roy S, Choudhuri SK.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lasing the DNA fragments through β-diketimine framed Knoevenagel condensed Cu(II) and Zn(II) complexes--an in vitro and in vivo approach.
    Raman N, Pravin N.
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan 24; 118():867-82. PubMed ID: 24161850
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells.
    Kuete V, Mbaveng AT, Zeino M, Fozing CD, Ngameni B, Kapche GD, Ngadjui BT, Efferth T.
    Phytomedicine; 2015 Nov 15; 22(12):1096-102. PubMed ID: 26547532
    [Abstract] [Full Text] [Related]

  • 17. Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer.
    Spengler G, Kincses A, Rácz B, Varga B, Watanabe G, Saijo R, Sekiya H, Tamai E, Maki J, Molnár J, Kawase M.
    Anticancer Res; 2018 Nov 15; 38(11):6181-6187. PubMed ID: 30396935
    [Abstract] [Full Text] [Related]

  • 18. Two palladium (II) complexes derived from halogen-substituted Schiff bases and 2-picolylamine induce parthanatos-type cell death in sensitive and multi-drug resistant CCRF-CEM leukemia cells.
    Zhou M, Boulos JC, Omer EA, Rudbari HA, Schirmeister T, Micale N, Efferth T.
    Eur J Pharmacol; 2023 Oct 05; 956():175980. PubMed ID: 37567459
    [Abstract] [Full Text] [Related]

  • 19. Apoptosis-inducing Effect of a Palladium(II) Complex-[PdCl(terpy)](sac).2H2O] on Ehrlich Ascites Carcinoma (EAC) in Mice.
    Ikitimur-Armutak EI, Ulukaya E, Gurel-Gurevin E, Yaylim I, Isbilen-Basok B, Sennazli G, Yuzbasioglu-Ozturk G, Sonmez K, Celik F, Kucukhuseyin O, Korkmaz G, Yilmaz VT, Zeybek SU.
    In Vivo; 2016 Oct 05; 30(4):457-64. PubMed ID: 27381609
    [Abstract] [Full Text] [Related]

  • 20. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S, Dutta P, Mookerjee A, Choudhuri SK.
    Chem Biol Interact; 2006 Feb 01; 159(2):90-103. PubMed ID: 16289015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.